XBB.1.5 and other subvariants do signal a change in how the virus is mutating. Here’s what this means for Australia and globally.
Academic rigor, journalistic flair
Articles on Epidemiology
Displaying 21 - 40 of 208 articles
While lung cancer rates have decreased by 43% in men, they have risen by 79% in women. New screening guidelines and recognizing early symptoms can help address the changing face of lung cancer.
Although chronic pain is recognized by scientists as a disease in its own right, it remains largely under-recognized, under-diagnosed and, above all, associated with numerous prejudices.
Long COVID impacts one in every five people who’ve had the virus. In the U.S., early research shows people of colour are most likely to develop long COVID. It has been called a mass-disabling event.
The evidence so far suggests this wave could be a shorter and smaller version of the Omicron BA.5 wave.
Financial support for science and research in Nigeria remains pathetic. This has led to the deterioration in the quantity and quality of trained virologists at universities.
While the majority of monkeypox cases thus far have been recorded among men who have sex with men, everyone is still at risk of contracting the disease.
Just because a variant spreads faster, it doesn’t necessarily mean it has a higher R0.
By late July 2022, monkeypox was present in more than 70 countries with significant spread in certain communities. As a result, the World Health Organization began taking steps to fight the virus.
The monkeypox virus, which is commonly found in West and Central Africa, is now causing many infections in the U.S., Europe and Latin America.
Our ability to use mathematical modelling is accelerating breakthrough discoveries in health care and biotechnology.
Allowing cats to roam unsupervised is detrimental to humans, wildlife and the cats themselves. Managing free-roaming cats should consider the risks they pose to other species.
The COVID-19 pandemic has seen an increase in wastewater testing to monitor the spread of the virus. But historical cases show that targeted surveillance can further marginalize vulnerable populations.
Achieving herd immunity via vaccination was always going to be a hard ask. Now it’s mathematically impossible.
Monte Carlo simulations can predict different potential outcomes because they provide for the presence of random variables or elements.
People want a simple answer. Is this action safe? But despite Anthony Fauci bouncing responsibility for COVID-19 risk assessment to individuals, your risk can’t be boiled down to one probability.
The risk of a household contact becoming infected is low. So it’s time to lift isolation requirements, now so many of us are immune to the virus.
This sort of precision complements health experts’ efforts, helping humans to be more precise and communicate more precisely.
Instead of making the lives of contact tracers easier, analysis shows the expensive technology missed contacts and added to their workload.
Endemic doesn’t mean we drop our guard, surrender to the virus or downgrade the threat the virus poses to individuals and the community.
Top contributors
-
Associate Professor, Epidemiology, Deakin University
-
Professor, School of Medicine, University of Connecticut
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Chair in Epidemiology, Deakin University
-
Professor in Mathematical Biology, The University of Melbourne
-
Professor of Epidemiology, Population Interventions Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne
-
Professor and Chair of Epidemiology, University of Michigan
-
Research Assistant Professor of Epidemiology, University of Michigan
-
Professor of Public Health, American University
-
Professor, epidemiological modelling of infectious diseases, UNSW Sydney
-
Ph.D. Student in Microbiology and Immunology, Vanderbilt Vaccine Center, Vanderbilt University
-
Professor and Director of Doherty Epidemiology, The University of Melbourne
-
Ph.D. Candidate in Chemical & Physical Biology, Vanderbilt Vaccine Center, Vanderbilt University
-
Clinical Professor of Medicine, University of California, San Francisco
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
